Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase 4 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Venous Thromboembolism 2 Thrombosis 2 Hemorrhage 2 Venous Thrombosis 1 Thromboembolism 1 Thrombocytopenia 1 Sarcoma 1 Pulmonary Embolism 1 Pancreatic Neoplasms 1 Liver Neoplasms 1 Hematoma 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Fibrosis 1 Carcinoma, Hepatocellular 1 Bone Neoplasms 1

Interventions

edoxaban 1 Tranexamic Acid 1 Sodium Chloride 1 Saline Solution 1 Heparin, Low-Molecular-Weight 1 Enoxaparin 1 Dalteparin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Thromboembolism × Enoxaparin × Clear all

NCT02444572 2021-07-29

ENOXACARE

Les Laboratoires des Médicaments Stériles

Phase 4 Completed

Gastrointestinal

Gastrointestinal Neoplasms, Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡